# Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)

> **NCT04358926** · NA · COMPLETED · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 30 (actual)

## Conditions studied

- COVID-19
- Desaturation of Blood

## Interventions

- **DEVICE:** Hyperbaric oxygen therapy

## Key facts

- **NCT ID:** NCT04358926
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-30
- **Primary completion:** 2020-10-15
- **Final completion:** 2020-11-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04358926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04358926, "Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04358926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*